The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms
Timo D. Müller(Anton Paar (Austria)), Matthias H. Tschöp(Helmholtz Zentrum München), Kirk M. Habegger(University of Alabama at Birmingham), Gunnar Kleinau(Humboldt-Universität zu Berlin), Renu Sah(University of Cincinnati Medical Center), Susanna M. Hofmann(Helmholtz Zentrum München), Carolin L. Piechowski(Charité - Universitätsmedizin Berlin), William Abplanalp(Cincinnati Children's Hospital Medical Center), Michael O. Thorner(Ames National Laboratory), Maximilian Bielohuby(Sanofi (Germany)), Nakul Bhardwaj(University of Cincinnati), Juliane Pratzka(Charité - Universitätsmedizin Berlin), Brian Finan(Eli Lilly (United States)), Martin Bidlingmaier(LMU Klinikum), Carola W. Meyer(Helmholtz Munich), Chitrang Trivedi(University of Cincinnati), Kerstin Stemmer(University of Augsburg), Chun‐Xia Yi(Netherlands Institute for Neuroscience), Jazzmin Hembree(University of Cincinnati), Kristy M. Heppner(Novo Nordisk (United States)), Richard D. DiMarchi(Indiana University Bloomington), Stephen C. Woods(University of Cincinnati), Bruce D. Gaylinn(University of Virginia), Heiko Krude(Humboldt-Universität zu Berlin), Nickki Ottaway(University of Cincinnati), Christine Raver(University of Cincinnati), Anne Müller(Humboldt-Universität zu Berlin), Paul T. Pfluger(Helmholtz Zentrum München), Jenna Holland(University of Cincinnati), David L. Smiley(Indiana University Bloomington), Radha Krishna(University of Cincinnati), Floyd R. Sallee(University of Cincinnati Medical Center), Heike Biebermann(Humboldt-Universität zu Berlin), Franziska Meyer(Charité - Universitätsmedizin Berlin), Diego Pérez–Tilve(University of Cincinnati Medical Center)
Cited by 85
Related Papers
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
|Nature Genetics|1998|1.7k
Anti-obesity drug discovery: advances and challenges
|Nature Reviews Drug Discovery|2021|983
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
A guide to analysis of mouse energy metabolism
|Nature Methods|2011|816